Katsuya Harada

Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: A putative post-traumatic stress disorder model

Kohfuku Kohda, Katsuya Harada, K. Katō et al. · Neuroscience · 2007 · 240 citations

Psychoneuroimmunology, Psychopathology, Stress Hormone +14

Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6)

Kinya Ishikawa, Masahiko Watanabe, Kazuo Yoshizawa et al. · Journal of Neurology Neurosurgery & Psychiatry · 1999 · 117 citations · Full text

Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: A comparison with diazepam and buspirone

Katsuya Harada, Masaki Aota, Tatsuo Inoue et al. · European Journal of Pharmacology · 2006 · 82 citations

Psychoactive Drug, Anxiolytic Activity, Psychiatry +11

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Takuya Maemoto, Miho Tada, Takuma Mihara et al. · Journal of Pharmacological Sciences · 2004 · 78 citations · Full text

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu et al. · European Journal of Pharmacology · 2012 · 60 citations

Alzheimer's Disease, Medicine, Cognitive Dysfunction +12